interview | DeepQure

top of page

For Patients
HyperQure
About HyperQure
Technology Pipeline
About HyperQure
Technology Pipeline
Resources
Blog
Media Coverage
Blog
Media Coverage
About
About DeepQure
Our Team
Our Advisors
Investor Relations
About DeepQure
Our Team
Our Advisors
Investor Relations

Blog
Media Coverage
Blog

DeepQure's HyperQure renal denervation system

DeepQure's HyperQure renal denervation system

Renal Denervation: A Market in Search of the Right Solution

Understand the reasons for the market's keen interest in renal denervation technologies today, and how this field is shaping up to offer an alternative to drugs in hypertension management

Aug 14, 2025

RDN clinical pathway for hypertensive patients

RDN clinical pathway for hypertensive patients

Renal Denervation’s Clinical Pathway: Who’s Involved?

Renal denervation involves different clinicians with different specialties. Learn about the clinical pathway for RDN from Dr Chang-Wook Jeong, co-founder and Chief Medical Officer of DeepQure.

Aug 5, 2025

© 2025 DeepQure Inc. All rights reserved.

This site and its contents are the property of DeepQure Inc and may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of DeepQure Inc.

HyperQure

About HyperQure

Resources

About

Investor Relations

For Patients
HyperQure
- About HyperQure
- Technology Pipeline
Resources
- Blog
- Media Coverage
About

bottom of page